Thyroid antibody study in people with diabetes
Part of Hormones & metabolism clinical trials.
This study looks at whether people with diabetes have higher levels of a thyroid antibody, which may indicate an increased risk for thyroid problems. By participating, you can help doctors understand the connection between diabetes and thyroid health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have been diagnosed with diabetes.
- You must not have a history of thyroid disease or thyroid surgery.
- You must not be taking thyroid medications or any medications that affect thyroid function.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks for early signs of type 1 diabetes in people with autoimmune thyroid disease. It is a screening study that may help you understand your risk for the future.
This study looks at whether the body's immune response to the thyroid is linked to breast cancer. It may help doctors understand how breast cancer behaves and how to treat it better.
This study looks at how thyroid function relates to type 2 diabetes. If you have type 2 diabetes, this research may help understand and possibly improve care.
This study looks at immune (defense system) and blood-sugar changes in people with type 1 diabetes, and in some other diabetes or autoimmune hormone conditions. It includes people who will have a specific abdominal surgery so doctors can safely study lymph node tissue.
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
This study enrolls people with islet autoantibodies, which are early markers for type 1 diabetes. It aims to understand who develops these antibodies and how they are linked to diabetes over time. No treatment is given—you just provide blood samples and answer questions.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.